{"id":"https://openalex.org/W4206207657","doi":"https://doi.org/10.1158/2326-6074.tumimm21-p054","title":"Abstract P054: Immune determinants of the association between tumor mutational burden and immunotherapy response across cancer types","display_name":"Abstract P054: Immune determinants of the association between tumor mutational burden and immunotherapy response across cancer types","publication_year":2022,"publication_date":"2022-01-01","ids":{"openalex":"https://openalex.org/W4206207657","doi":"https://doi.org/10.1158/2326-6074.tumimm21-p054"},"language":"en","primary_location":{"id":"doi:10.1158/2326-6074.tumimm21-p054","doi":"https://doi.org/10.1158/2326-6074.tumimm21-p054","is_oa":false,"landing_page_url":"https://doi.org/10.1158/2326-6074.tumimm21-p054","pdf_url":null,"source":{"id":"https://openalex.org/S2765010658","display_name":"Cancer Immunology Research","issn_l":"2326-6066","issn":["2326-6066","2326-6074"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Immunology Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5024945091","display_name":"Neelam Sinha","orcid":"https://orcid.org/0000-0001-6496-224X","observed_orcids":["https://orcid.org/0000-0001-6496-224X"]},"institutions":[{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Neelam Sinha","raw_affiliation_strings":["1Cancer Data Science Lab, National Cancer Institute, Bethesda, MD,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Cancer Data Science Lab, National Cancer Institute, Bethesda, MD,","institution_ids":["https://openalex.org/I4210140884"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004895242","display_name":"Sanju Sinha","orcid":"https://orcid.org/0000-0002-2688-0603","observed_orcids":["https://orcid.org/0000-0002-2688-0603"]},"institutions":[{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sanju Sinha","raw_affiliation_strings":["1Cancer Data Science Lab, National Cancer Institute, Bethesda, MD,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Cancer Data Science Lab, National Cancer Institute, Bethesda, MD,","institution_ids":["https://openalex.org/I4210140884"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5104025010","display_name":"Christina Valero","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Christina Valero","raw_affiliation_strings":["2Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY,","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000317216","display_name":"Alejandro A. Sch\u00e4ffer","orcid":"https://orcid.org/0000-0002-2147-8033","observed_orcids":["https://orcid.org/0000-0002-2147-8033"]},"institutions":[{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alejandro A. Schaffer","raw_affiliation_strings":["3National Cancer Institute, Bethesda, MD,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3National Cancer Institute, Bethesda, MD,","institution_ids":["https://openalex.org/I4210140884"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007209727","display_name":"Kenneth Aldape","orcid":"https://orcid.org/0000-0001-5119-7550","observed_orcids":["https://orcid.org/0000-0001-5119-7550"]},"institutions":[{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kenneth Aldape","raw_affiliation_strings":["3National Cancer Institute, Bethesda, MD,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3National Cancer Institute, Bethesda, MD,","institution_ids":["https://openalex.org/I4210140884"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013716980","display_name":"Kevin Litchfield","orcid":"https://orcid.org/0000-0002-3725-0914","observed_orcids":["https://orcid.org/0000-0002-3725-0914"]},"institutions":[{"id":"https://openalex.org/I2801081054","display_name":"The Francis Crick Institute","ror":"https://ror.org/04tnbqb63","country_code":"GB","type":"facility","lineage":["https://openalex.org/I2801081054"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Kevin Litchfield","raw_affiliation_strings":["4The Francis Crick Institute, London, United Kingdom,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4The Francis Crick Institute, London, United Kingdom,","institution_ids":["https://openalex.org/I2801081054"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080223712","display_name":"Timothy An-thy Chan","orcid":"https://orcid.org/0000-0002-9265-0283","observed_orcids":["https://orcid.org/0000-0002-9265-0283"]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]},{"id":"https://openalex.org/I4405287411","display_name":"Cleveland Clinic Research","ror":"https://ror.org/053229s83","country_code":"US","type":"facility","lineage":["https://openalex.org/I1316902750","https://openalex.org/I4405287411"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Timothy A. Chan","raw_affiliation_strings":["5Lerner Research Institute, Cleveland Clinic, Cleveland, OH,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"5Lerner Research Institute, Cleveland Clinic, Cleveland, OH,","institution_ids":["https://openalex.org/I1316902750","https://openalex.org/I4405287411"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084443648","display_name":"Luc G.T. Morris","orcid":"https://orcid.org/0000-0002-4417-2280","observed_orcids":["https://orcid.org/0000-0002-4417-2280"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Luc G. T. Morris","raw_affiliation_strings":["6Memorial Sloan Kettering Cancer Center, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"6Memorial Sloan Kettering Cancer Center, New York, NY","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5063492133","display_name":"Eytan Ruppin","orcid":"https://orcid.org/0000-0002-7862-3940","observed_orcids":["https://orcid.org/0000-0002-7862-3940"]},"institutions":[{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Eytan Ruppin","raw_affiliation_strings":["3National Cancer Institute, Bethesda, MD,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3National Cancer Institute, Bethesda, MD,","institution_ids":["https://openalex.org/I4210140884"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":5,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"10","issue":"1_Supplement","first_page":"P054","last_page":"P054"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11287","display_name":"Cancer Genomics and Diagnostics","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tumor-mutational-burden","display_name":"tumor mutational burden","score":0.9940000176429749},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.8240000009536743},{"id":"https://openalex.org/keywords/pembrolizumab","display_name":"pembrolizumab","score":0.9769999980926514},{"id":"https://openalex.org/keywords/pd-1","display_name":"PD-1","score":0.675000011920929},{"id":"https://openalex.org/keywords/tumor-immune-microenvironment","display_name":"tumor immune microenvironment","score":0.8169999718666077},{"id":"https://openalex.org/keywords/m1-macrophages","display_name":"M1 macrophages","score":0.8140000104904175},{"id":"https://openalex.org/keywords/immunotherapy-response-prediction","display_name":"immunotherapy response prediction","score":0.7549999952316284},{"id":"https://openalex.org/keywords/biomarker-predictive-value","display_name":"biomarker predictive value","score":0.41100001335144043},{"id":"https://openalex.org/keywords/cervical-squamous-cell-carcinoma","display_name":"cervical squamous cell carcinoma","score":0.8560000061988831},{"id":"https://openalex.org/keywords/rare-tumor","display_name":"rare tumor","score":0.7649999856948853},{"id":"https://openalex.org/keywords/msk-impact","display_name":"MSK-IMPACT","score":0.6800000071525574},{"id":"https://openalex.org/keywords/the-cancer-genome-atlas","display_name":"TCGA","score":0.5649999976158142},{"id":"https://openalex.org/keywords/cd8-t-cells","display_name":"CD8+ T cells","score":0.6919999718666077}],"concepts":[{"id":"https://openalex.org/C2776107976","wikidata":"https://www.wikidata.org/wiki/Q1786433","display_name":"Tumor microenvironment","level":3,"score":0.6829845905303955},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.667999267578125},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.6605150699615479},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.632289707660675},{"id":"https://openalex.org/C2780057760","wikidata":"https://www.wikidata.org/wiki/Q13896859","display_name":"Pembrolizumab","level":4,"score":0.6153863072395325},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6038823127746582},{"id":"https://openalex.org/C2781197716","wikidata":"https://www.wikidata.org/wiki/Q864574","display_name":"Biomarker","level":2,"score":0.577427864074707},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.5134116411209106},{"id":"https://openalex.org/C2780674031","wikidata":"https://www.wikidata.org/wiki/Q2012719","display_name":"Cancer immunotherapy","level":4,"score":0.47929826378822327},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.45817112922668457},{"id":"https://openalex.org/C167672396","wikidata":"https://www.wikidata.org/wiki/Q417800","display_name":"CD8","level":3,"score":0.45460763573646545},{"id":"https://openalex.org/C2780851360","wikidata":"https://www.wikidata.org/wiki/Q21686041","display_name":"Immune checkpoint","level":4,"score":0.4357183873653412},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.413821816444397},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.39576369524002075},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3501049280166626},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3116825819015503},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.24449265003204346},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.06270110607147217}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/2326-6074.tumimm21-p054","doi":"https://doi.org/10.1158/2326-6074.tumimm21-p054","is_oa":false,"landing_page_url":"https://doi.org/10.1158/2326-6074.tumimm21-p054","pdf_url":null,"source":{"id":"https://openalex.org/S2765010658","display_name":"Cancer Immunology Research","issn_l":"2326-6066","issn":["2326-6066","2326-6074"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Immunology Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9907000064849854,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4225597914","https://openalex.org/W4221041351","https://openalex.org/W4385754563","https://openalex.org/W3132994077","https://openalex.org/W3098118704","https://openalex.org/W4221001936","https://openalex.org/W2747774814","https://openalex.org/W2947394248","https://openalex.org/W4393203256","https://openalex.org/W2969338379"],"abstract_inverted_index":{"Abstract":[0],"The":[1],"FDA":[2],"has":[3,175],"recently":[4],"approved":[5],"a":[6,17,53,124,167,301,347],"high":[7,185,204],"tumor":[8,71,241,382],"mutational":[9,383],"burden":[10,384],"(TMB-High,":[11],"defined":[12],"by":[13,155,220],"\u226510":[14],"mutations/Mb)":[15],"as":[16],"biomarker":[18,44,319],"for":[19,288],"the":[20,59,70,77,101,109,116,137,157,179,198,277,311,315,379],"treatment":[21],"of":[22,55,79,84,103,108,111,126,170,187,193,276,317,336,378],"advanced":[23],"solid":[24],"tumors":[25],"with":[26,123,130,166,203,211],"pembrolizumab,":[27],"an":[28,222],"immune":[29,72,139,258],"checkpoint":[30],"inhibitor":[31],"(ICI)":[32],"that":[33,41,69,141,184,214,233,330,345],"targets":[34],"PD1.":[35],"However,":[36],"recent":[37],"studies":[38],"have":[39,64],"shown":[40],"this":[42,62,96,121,271,325],"TMB-high":[43,318],"is":[45],"only":[46],"able":[47],"to":[48,81,135,240,309],"stratify":[49,82],"ICI":[50,85,292,337],"responders":[51,83],"in":[52,89,115,197,280,320,339],"subset":[54],"cancer":[56,91,113,149,201,265,283,322,389],"types,":[57,284],"where":[58,173],"mechanisms":[60],"underlying":[61],"observation":[63],"remained":[65],"unknown.":[66],"We":[67,118,182],"hypothesized":[68],"microenvironment":[73],"(TME)":[74],"may":[75,237,332],"determine":[76,143],"ability":[78],"high-TMB":[80],"(termed":[86],"TMB":[87,131,144,174,205,262,278,290],"power)":[88],"each":[90],"type.":[92],"To":[93],"systematically":[94],"study":[95,348],"hypothesis,":[97],"we":[98,273],"first":[99],"inferred":[100],"levels":[102,186,192],"31":[104],"immune-related":[105],"factors":[106,140,259],"characteristic":[107],"TME":[110,199],"different":[112,148],"types":[114,202,266,390],"TCGA.":[117],"next":[119],"integrated":[120],"information":[122],"cohort":[125,152,161,169],"2,277":[127],"ICI-treated":[128],"patients":[129,164],"and":[132,190,225,232,291,385,400],"response":[133,224,293,338,387],"measures,":[134],"identify":[136],"key":[138],"can":[142,306],"power":[145,263,279],"across":[146,264,388],"14":[147],"types.":[150,323],"This":[151],"was":[153],"created":[154],"collating":[156],"largest":[158],"publicly":[159,298],"available":[160,299],"comprising":[162],"1959":[163],"together":[165],"new":[168,321],"318":[171],"patients,":[172],"been":[176],"quantified":[177],"using":[178],"MSK-IMPACT":[180],"panel.":[181],"find":[183],"M1":[188,215],"macrophages":[189,216],"low":[191],"resting":[194,234],"dendritic":[195,235],"cells":[196,229,236],"characterize":[200],"power.":[206],"These":[207,304],"findings":[208],"are":[209,295],"aligned":[210],"prior":[212],"reports":[213],"could":[217],"be":[218,307,333,350],"anti-tumorigenic":[219],"fostering":[221],"inflammation":[223],"activating":[226],"CD8":[227],"T":[228,245],"against":[230],"tumor,":[231],"induce":[238],"tolerance":[239],"antigens":[242],"via":[243],"inducing":[244],"cell":[246,342],"death":[247],"or":[248],"their":[249],"anergic":[250],"state.":[251],"A":[252],"model":[253],"based":[254],"on":[255,300],"these":[256],"two":[257],"strongly":[260,334],"predicts":[261],"(Spearman":[267],"Rho=0.76,":[268],"P<3.6E-04).":[269],"Using":[270],"model,":[272],"provide":[274],"predictions":[275,305],"nine":[281],"additional":[282],"including":[285],"rare":[286],"cancers,":[287],"which":[289],"data":[294],"not":[296],"yet":[297],"large":[302],"scale.":[303],"used":[308],"prioritize":[310],"clinical":[312],"trials":[313],"testing":[314],"usage":[316],"In":[324],"line,":[326],"our":[327],"analysis":[328],"indicates":[329],"TMB-High":[331],"predictive":[335],"cervical":[340],"squamous":[341],"carcinoma,":[343],"suggesting":[344],"such":[346],"should":[349],"prioritized.":[351],"Citation":[352],"Format:":[353],"Neelam":[354],"Sinha,":[355,357],"Sanju":[356],"Christina":[358],"Valero,":[359],"Alejandro":[360],"A.":[361,368],"Schaffer,":[362],"Kenneth":[363],"Aldape,":[364],"Kevin":[365],"Litchfield,":[366],"Timothy":[367],"Chan,":[369],"Luc":[370],"G.":[371],"T.":[372],"Morris,":[373],"Eytan":[374],"Ruppin.":[375],"Immune":[376],"determinants":[377],"association":[380],"between":[381],"immunotherapy":[386],"[abstract].":[391],"In:":[392],"Abstracts:":[393],"AACR":[394],"Virtual":[395],"Special":[396],"Conference:":[397],"Tumor":[398],"Immunology":[399],"Immunotherapy;":[401],"2021":[402],"Oct":[403],"5-6.":[404],"Philadelphia":[405],"(PA):":[406],"AACR;":[407],"Cancer":[408],"Immunol":[409],"Res":[410],"2022;10(1":[411],"Suppl):Abstract":[412],"nr":[413],"P054.":[414]},"counts_by_year":[],"updated_date":"2026-10-24T09:50:30.924529","created_date":"2022-01-25T00:00:00"}